BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 12, 2007
View Archived Issues
Pharmacokinetics of GSK-221149A studied to prepare for clinical trial
Read More
C-reactive protein, neopterin correlate with PRTX-100 dose in healthy subjects
Read More
Antiinflammatory effects of the GABA-B agonist baclofen shown in mice
Read More
Recent Abbott patents describe new ACC inhibitors
Read More
Novel chemokine CCR5 receptor antagonists emerge from Roche R&D
Read More
Recent Bayer patent describes new agents for thromboembolic disorders
Read More
Alpharma obtains U.S. rights to Diractin from IDEA
Read More
Power3 Medical Products reports preliminary results of international validation study of PD test
Read More
Iomai begins phase I/II trial of immunostimulant patch with H5N1 influenza vaccine
Read More
Series C financing to fund Trophos' TRO-19622 and TRO-40303
Read More
Update on Pozen and AstraZeneca's PN-400 program
Read More
NeuroSearch begins phase II study of ABT-894 for neuropathic pain
Read More
Spectrum begins enrolling patients in second pivotal phase III trial of EOquin
Read More
OSI Prosidion reports results from metformin and PSN-9301 interaction study
Read More
IL-22 blockade shows benefit in mouse model of rheumatoid arthritis
Read More
Positive first-in-human trial results of novel endothelin antagonist from Actelion
Read More
Lilly launches Cialis for erectile dysfunction in Japan
Read More
Innogenetics to discontinue investment in candidate HCV E1 vaccine
Read More
Affymetrix enters into licensing agreement with Empire Genomics
Read More
Penwest and Otsuka enter into R&D agreement
Read More
FDA approves Adventrx clinical development plan for ANX-514
Read More
XTL Biopharmaceuticals begins phase IIb trial of bicifadine for diabetic neuropathic pain
Read More
Enrollment begins for CeNeS and Ergomed's phase II trial of CNS-5161 for cancer pain
Read More
Moberg Derma initiates enrollment of phase III trial of K-101 for onychomycosis
Read More